284 related articles for article (PubMed ID: 23198155)
1. Immunopathogenesis of human T-cell leukemia virus type-1-associated myelopathy/tropical spastic paraparesis: recent perspectives.
Saito M; Bangham CR
Leuk Res Treatment; 2012; 2012():259045. PubMed ID: 23198155
[TBL] [Abstract][Full Text] [Related]
2. Immunogenetics and the Pathological Mechanisms of Human T-Cell Leukemia VirusType 1- (HTLV-1-)Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
Saito M
Interdiscip Perspect Infect Dis; 2010; 2010():478461. PubMed ID: 20169122
[TBL] [Abstract][Full Text] [Related]
3. Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Nozuma S; Kubota R; Jacobson S
J Neurovirol; 2020 Oct; 26(5):652-663. PubMed ID: 32705480
[TBL] [Abstract][Full Text] [Related]
4. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
5. Mediators of central nervous system damage during the progression of human T-cell leukemia type I-associated myelopathy/tropical spastic paraparesis.
Barmak K; Harhaj EW; Wigdahl B
J Neurovirol; 2003 Oct; 9(5):522-9. PubMed ID: 13129766
[TBL] [Abstract][Full Text] [Related]
6. Current Perspectives in Human T-Cell Leukemia Virus Type 1 Infection and Its Associated Diseases.
Miura M; Naito T; Saito M
Front Med (Lausanne); 2022; 9():867478. PubMed ID: 35463007
[TBL] [Abstract][Full Text] [Related]
7. Immunopathogenesis of HTLV-1-assoaciated myelopathy/tropical spastic paraparesis (HAM/TSP).
Fuzii HT; da Silva Dias GA; de Barros RJ; Falcão LF; Quaresma JA
Life Sci; 2014 May; 104(1-2):9-14. PubMed ID: 24704970
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
Rafatpanah H; Farid Hosseini R; Pourseyed SH
Iran J Basic Med Sci; 2013 Mar; 16(3):235-41. PubMed ID: 24470869
[TBL] [Abstract][Full Text] [Related]
9. Immunopathogenesis of HTLV-I-associated myelopathy/tropical spastic paraparesis.
Nakamura T
Ann Med; 2000 Dec; 32(9):600-7. PubMed ID: 11209967
[TBL] [Abstract][Full Text] [Related]
10. Neuroimmunology of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis.
Nozuma S; Jacobson S
Front Microbiol; 2019; 10():885. PubMed ID: 31105674
[TBL] [Abstract][Full Text] [Related]
11. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
[TBL] [Abstract][Full Text] [Related]
12. Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Enose-Akahata Y; Jacobson S
Retrovirology; 2019 Nov; 16(1):35. PubMed ID: 31783764
[TBL] [Abstract][Full Text] [Related]
13. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Saito M; Matsuzaki T; Satou Y; Yasunaga J; Saito K; Arimura K; Matsuoka M; Ohara Y
Retrovirology; 2009 Feb; 6():19. PubMed ID: 19228429
[TBL] [Abstract][Full Text] [Related]
14. Immunopathogenesis and Cellular Interactions in Human T-Cell Leukemia Virus Type 1 Associated Myelopathy/Tropical Spastic Paraparesis.
Aghajanian S; Teymoori-Rad M; Molaverdi G; Mozhgani SH
Front Microbiol; 2020; 11():614940. PubMed ID: 33414779
[TBL] [Abstract][Full Text] [Related]
15. Role of Integrin Signaling Activation on the Development of Human T Cell Leukemia Virus-1 (HTLV-1)-Associated Myelopathy/Tropical Spastic Paraparesis: Its Relationship to HTLV-1-Infected CD4
Nakamura T; Satoh K; Nakamura H; Fukushima N; Nishiura Y; Furuya T; Ichinose K
AIDS Res Hum Retroviruses; 2018 Apr; 34(4):331-336. PubMed ID: 29400072
[TBL] [Abstract][Full Text] [Related]
16. Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis.
Yamano Y; Sato T
Front Microbiol; 2012; 3():389. PubMed ID: 23162542
[TBL] [Abstract][Full Text] [Related]
17. Pentosan Polysulfate Demonstrates Anti-human T-Cell Leukemia Virus Type 1 Activities
Ma G; Yasunaga JI; Ohshima K; Matsumoto T; Matsuoka M
J Virol; 2019 Aug; 93(16):. PubMed ID: 31167921
[TBL] [Abstract][Full Text] [Related]
18. Possible implication of NFKB1A and NKG2D genes in susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian patients infected with HTLV-1.
Talledo M; López G; Huyghe JR; Verdonck K; González E; Clark D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
J Med Virol; 2012 Feb; 84(2):319-26. PubMed ID: 22170554
[TBL] [Abstract][Full Text] [Related]
19. HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy.
Nakamura T
Folia Neuropathol; 2009; 47(2):182-94. PubMed ID: 19618340
[TBL] [Abstract][Full Text] [Related]
20. Role of IL-21 in HTLV-1 infections with emphasis on HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Rajaei T; Farajifard H; Rafatpanah H; Bustani R; Valizadeh N; Rajaei B; Rezaee SA
Med Microbiol Immunol; 2017 Jun; 206(3):195-201. PubMed ID: 28378248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]